European disease registry on Retinopathy of Prematurity (ROP)

Recruiting

• Conditions: H35.1; Retinopathy of prematurity

• Registration Number: DRKS00025138
• Lead Sponsor: niversitätsklinikum Greifswald

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-08-19
• Results First Posted: 2023-08-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

ROP requiring treatment according to the respective national ROP screening and treatment guidelines

Exclusion Criteria

Denial or absence of consent for documentation and storage of personal data by parents or legal guardians

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
- Collecting baseline demographic data from infants treated for ROP <br><br>- Gathering information on ROP characteristics <br><br>- Documenting treatment and follow-up patterns <br><br>- Analyzing outcomes of severe ROP (both ophthalmologic as well as neurodevelopmental)

Secondary Outcome Measures

Name	Time	Method
• Documenting number of infants treated for ROP<br>• Analyzing incidence of ROP requiring treatment from participating centers and countries